Generate Biomedicines, Inc. Sets Initial Public Offering at $16.00 per Share Generate Biomedicines, Inc. announces its IPO pricing at $16 per share. The company aims to raise $400 million to advance its innovative biotechnology efforts.

Generate Biomedicines, Inc. Sets Initial Public Offering at $16.00 per Share #United_States #Somerville #Initial_Public_Offering #Generate_Biomedicines #Nasdaq_GENB